XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Net income $ 14,400 $ 47,319
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization expense 110,946 69,032
Depreciation expense 2,226 1,869
Deferred income taxes (3,453) (7,925)
Stock-based compensation expense 22,342 17,487
Non-cash lease benefit (60) (44)
Non-cash interest expense for amortization of debt discount and issuance costs 2,722 3,384
Net accretion for deferred royalty obligation 2,014  
Loss on extinguishment of debt   7,184
Net amortization of premiums and discounts on investments (588) (1,138)
Change in fair value of contingent consideration (1,144)  
Changes in operating assets and liabilities:    
Accounts receivable 15,509 (4,330)
Inventory (2,588) 4,470
Prepaid expenses and other assets (21,120) (11,688)
Accounts payable 6,956 (6,144)
Accrued liabilities (12,086) 982
Accrued rebates, returns and discounts (8,239) 8,877
Net cash provided by operating activities 127,837 129,335
Investing activities    
Purchases of property and equipment (863) (838)
Purchases of marketable securities (42,501) (73,403)
Maturities of marketable securities 30,769 47,207
Net cash used in investing activities (12,595) (27,034)
Financing activities    
Proceeds from issuances of common stock from employee stock purchase plan 506 356
Proceeds from the exercise of stock options 1,860 9,924
Payments made for employee stock tax withholdings (11,021) (18,749)
Repurchases of common stock, including the ASR agreement (25,104) (35,000)
Repayment of term notes (32,292) (91,667)
Redemption of 2026 Convertible Notes, including premium and redemption costs   (33,218)
Payments made for deferred purchase price for acquisition (7,555)  
Net cash used in financing activities (73,606) (168,354)
Net increase (decrease) in cash, cash equivalents and restricted cash 41,636 (66,053)
Cash, cash equivalents and restricted cash at beginning of period 96,612 239,994
Cash, cash equivalents and restricted cash at end of period 138,248 173,941
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:    
Cash and cash equivalents 117,348 172,894
Restricted cash 20,900 1,047
Total cash, cash equivalents and restricted cash 138,248 173,941
Supplemental disclosure of cash flow information    
Cash paid for interest 35,541 29,542
Cash paid for income taxes 32,273 35,881
Supplemental disclosure of non-cash activities    
Acquisition of property and equipment included in accounts payable and accrued liabilities $ 124 200
Miscellaneous costs of redemption of 2026 Convertible Notes   $ 27